Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease
Related Experiment Video
Updated: Nov 4, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
C Kawanishi1, K Suzuki, T Odawara
1Department of Psychiatry, Yokohama City University, School of Medicine, Japan.
Abstract:
We performed a quantitative neuropathological investigation of senile plaques and neurofibrillary tangles in the brains of 14 Japanese patients with diffuse Lewy body disease (DLBD), and examined apolipoprotein E (APOE) gene polymorphism in these patients. Most DLBD brains had as many senile plaques as those with Alzheimer-type dementia (ATD), but fewer neurofibrillary tangles. The APOE epsilon 4 allele frequency in DLBD was 39.3%, similar to that previously reported in pathologically diagnosed ATD. DLBD and ATD are clinically and pathologically distinct, but may have common mechanisms with regard to the formation of amyloid deposition based on these findings. Future investigation of the pure form of DLBD may clarify the association between Lewy body dementia and APOE.
More Related Videos
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Neural Regulation
Alzheimer Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Lysosomal Hydrolases

